1. GW420867X, anew non-nucleoside reverse transcriptase inhibitor (NNRTI): initial phase I evaluation;Prince;Antiviral Res,1999
2. Kleim J Burt V Maguire M Mutch P Hazen R St. Clair M GW420867X: a novel quinoxaline-class NNRTI of HIV-1 with improved antiretroviral properties in the presence of human serum and its components [abstract 599] January 31 to February 4, 1999
3. Long-term exposure of HIV type 1-infected cell cultures to combinations of the novel quinoxaline GW420867X with lamivudine, abacavir, and a variety of nonnucleoside reverse transcriptase inhibitors;Balzarini;AIDS Res Hum Retroviruses,2000
4. Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication;Kleim;Antimicrob Agents Chemother,1993
5. Kleim J Burt V Maguire M Ferris R Hazen RJ Roberts G St. Clair M NNRTI GW420867X: comparative evaluation of the in vitro resistance profile [abstract 600] January 31 to February 4, 1999